BRAIN Biotech AG
Develops enzymes and microorganisms for the food, chemical, and life sciences sectors.
BNN | F
Overview
Corporate Details
- ISIN(s):
- DE0005203947 (+1 more)
- LEI:
- 391200JKPVHLD6JLZ107
- Country:
- Germany
- Address:
- Darmstädter Straße 34-36, 64673 Zwingenberg
- Website:
- https://www.brain-biotech.com/
Description
BRAIN Biotech AG is an industrial biotechnology company specializing in the discovery, development, and production of specialty enzymes, high-performance microorganisms, and bioactive compounds. The company provides tailor-made biosolutions and contract research and development (R&D) services to partners in the food, chemical, and life sciences sectors. Core competencies include enzyme technology, microbial strain development, and bioprocess development. By leveraging an advanced technology portfolio, which includes proprietary platforms for enzyme discovery and genome editing, the company enables its partners to create more sustainable and efficient industrial products and processes, contributing to the bioeconomy.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2024-08-29 07:30 |
BRAIN Biotech AG presents strong cash position with its 9M reporting and is for…
|
English | HTML • 18.5 KB | ||
| 2024-08-29 00:00 |
Q3 statement / Q3 financial report 2023/2024
|
English | PDF • 613.4 KB | ||
| 2024-05-29 09:00 |
BRAIN Biotech AG announces the appointment of Erik de Vries as Senior Business …
|
English | HTML • 15.6 KB | ||
| 2024-05-28 07:30 |
BRAIN Biotech AG receives major milestone payment and stays on-track to achieve…
|
English | HTML • 19.5 KB | ||
| 2024-05-28 00:00 |
Halbjahresfinanzbericht nach WpHG für den Zeitraum vom 01.10.2023 bis zum 31.03…
|
German | HTML • 98.1 KB | ||
| 2024-05-28 00:00 |
Half-yearly financial report 2023/2024
|
English | PDF • 209.4 KB | ||
| 2024-05-14 17:20 | English | HTML • 4.0 KB | |||
| 2024-05-14 00:00 |
Hinweis auf Halbjahresfinanzbericht vom 01.10.2023 bis zum 31.03.2024
|
German | HTML • 5.8 KB | ||
| 2024-04-16 11:20 |
BRAIN Biotech AG takes next step to optimize group structure
|
English | HTML • 12.3 KB | ||
| 2024-03-14 09:00 |
Beverages made from vine leaves: Sustainable drinking pleasure based on agricul…
|
English | HTML • 13.0 KB | ||
| 2024-03-12 17:17 |
Results of the Annual General Meeting 2024 for the financial year 2022/23 of BR…
|
English | HTML • 12.8 KB | ||
| 2024-03-05 08:00 |
Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfull…
|
English | HTML • 17.4 KB | ||
| 2024-02-29 20:40 |
BRAIN Biotech AG successfully placed EUR 5.0 million convertible bond for the f…
|
English | HTML • 11.7 KB | ||
| 2024-02-29 20:06 |
BRAIN Biotech AG: Issuance of EUR 5 million convertible bond with exclusion of …
|
English | HTML • 7.7 KB | ||
| 2024-02-28 07:30 |
3M FY 23/24: BRAIN Biotech looks optimistic to stay on the growth path for fis…
|
English | HTML • 19.7 KB |
Automate Your Workflow. Get a real-time feed of all BRAIN Biotech AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BRAIN Biotech AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BRAIN Biotech AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-03 | Schneiders, Michael | Board | Buy | None | 25,000.00 EUR |
| 2025-01-16 | Moelker, Adriaan | Board | Buy | None | 35,795.96 EUR |
Peer Companies
